CA2603334A1 - Preparations intraveineuses de pyridoxal 5'-phosphate et procede de preparation et utilisations associes - Google Patents

Preparations intraveineuses de pyridoxal 5'-phosphate et procede de preparation et utilisations associes Download PDF

Info

Publication number
CA2603334A1
CA2603334A1 CA002603334A CA2603334A CA2603334A1 CA 2603334 A1 CA2603334 A1 CA 2603334A1 CA 002603334 A CA002603334 A CA 002603334A CA 2603334 A CA2603334 A CA 2603334A CA 2603334 A1 CA2603334 A1 CA 2603334A1
Authority
CA
Canada
Prior art keywords
pyridoxal
phosphate
sterile solution
solution contains
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002603334A
Other languages
English (en)
Inventor
Albert Friesen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicure International Inc
Original Assignee
Medicure International Inc.
Albert Friesen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002503087A external-priority patent/CA2503087A1/fr
Application filed by Medicure International Inc., Albert Friesen filed Critical Medicure International Inc.
Priority to CA002603334A priority Critical patent/CA2603334A1/fr
Publication of CA2603334A1 publication Critical patent/CA2603334A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002603334A 2005-03-30 2006-03-30 Preparations intraveineuses de pyridoxal 5'-phosphate et procede de preparation et utilisations associes Abandoned CA2603334A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002603334A CA2603334A1 (fr) 2005-03-30 2006-03-30 Preparations intraveineuses de pyridoxal 5'-phosphate et procede de preparation et utilisations associes

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA002503087A CA2503087A1 (fr) 2005-03-30 2005-03-30 Formulations injectables de 5'-phosphate de pyridoxal et methode de preparation connexe
CA2,503,087 2005-03-30
PCT/CA2006/000467 WO2006102748A1 (fr) 2005-03-30 2006-03-30 Preparations intraveineuses de pyridoxal 5'-phosphate et procede de preparation et utilisations associes
CA002603334A CA2603334A1 (fr) 2005-03-30 2006-03-30 Preparations intraveineuses de pyridoxal 5'-phosphate et procede de preparation et utilisations associes

Publications (1)

Publication Number Publication Date
CA2603334A1 true CA2603334A1 (fr) 2006-10-05

Family

ID=38830297

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002603334A Abandoned CA2603334A1 (fr) 2005-03-30 2006-03-30 Preparations intraveineuses de pyridoxal 5'-phosphate et procede de preparation et utilisations associes

Country Status (1)

Country Link
CA (1) CA2603334A1 (fr)

Similar Documents

Publication Publication Date Title
JP2602947B2 (ja) ジホスホン酸誘導体経口医薬組成物
JP5886632B2 (ja) オキシコドンおよびナロキソンを含む即時放出医薬組成物
EP3505161B1 (fr) Composition pharmaceutique sublinguale d'édaravone et de (+)-2-bornéol
HUE028195T2 (en) Coated tablet in mouth
JP2022540706A (ja) 鎮静作用のないデクスメデトミジン治療レジメン
MX2010004716A (es) Metodo para tratar la deficiencia de vitamina b12.
TWI763632B (zh) 用於重症治療時之鎮靜方法及非口服調配物
JP7091477B2 (ja) エダラボン医薬組成物
CA2011063C (fr) Compose pharmaceutique de nicardipine pour administration parenterale
US20130209584A1 (en) Pharmaceutical formulations of nitrite and uses thereof
US20200390691A1 (en) Compositions, devices, and methods for the treatment of overdose and reward-based disorders
JP3872834B2 (ja) メイラード反応抑制剤
US20090018106A1 (en) Intravenous formulations of pyridoxal 5'- phosphate and method of preparation
GB2577363A (en) Liquid pharmaceutical composition for oral administration comprising paracetamol and codeine phosphate
WO2010087358A1 (fr) Nouvelle composition
CA2603334A1 (fr) Preparations intraveineuses de pyridoxal 5'-phosphate et procede de preparation et utilisations associes
WO2020185214A1 (fr) Comprimés à désintégration orale comprenant du glycopyrrolate et procédés pour augmenter la biodisponibilité
CN110693882A (zh) 一种舌下用药物组合物
IE911698A1 (en) Therapeutic compound
CA2043106A1 (fr) Agent therapeutique
JP2521463B2 (ja) 塩酸ジラゼプ持効性錠剤
US20200323780A1 (en) Bilayer combination tablet for oral administration containing tramadol and celecoxib
CA2045294A1 (fr) Agent therapeutique
KR960008229B1 (ko) 캡토프릴 서방성 정제 및 그의 제조방법
WO2019211261A1 (fr) Méthodes de traitement du syndrome de douleur régionale complexe (sdrc) ou de symptômes comprenant l'administration d'acide néridronique

Legal Events

Date Code Title Description
FZDE Discontinued